| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 08/29/2013 | US20130224305 Methods of identifying insect-trpa1 modulators |
| 08/29/2013 | US20130224287 Liposome-Based Construct Comprising a Peptide Modified Through Hydrophobic Moieties |
| 08/29/2013 | US20130224285 Estrogen receptor alpha polypeptide sequence, diagnostic and therapeutic applications thereof |
| 08/29/2013 | US20130224246 Modified hepatitis c virus proteins |
| 08/29/2013 | US20130224222 Methods and assays for treating or preventing obesity and/or diabetes or increasing insulin sensitivity |
| 08/29/2013 | US20130224221 Biomarkers for schizophrenia |
| 08/29/2013 | US20130224209 Methods for diagnosing and treating prostate and lung cancer |
| 08/29/2013 | US20130224208 Glioma treatment method, glioma testing method, method for delivering desired substance to glioma, and drugs used in these methods |
| 08/29/2013 | US20130224204 Method of Treatment Based on ATAD2 Inhibitors |
| 08/29/2013 | US20130224194 Methods and compositions for diagnostic use in cancer patients |
| 08/29/2013 | US20130224193 Methods and compositions for diagnostic use in cancer patients |
| 08/29/2013 | US20130224192 Method for the prognosis of the progression of cancer |
| 08/29/2013 | US20130224191 Notum protein modulators and methods of use |
| 08/29/2013 | US20130224189 Tweak receptor |
| 08/29/2013 | US20130224174 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-trna synthetases |
| 08/29/2013 | US20130224117 Latent variable approach to the identification and/or diagnosis of cognitive disorders and/or behaviors and their endophenotypes |
| 08/29/2013 | US20130224116 Markers of Endothelial Progenitor Cells and Uses Thereof |
| 08/29/2013 | US20130220835 Polymeric vdat nanoparticles for use in biosensors |
| 08/29/2013 | US20130220832 Electronic methods for the detection of analytes |
| 08/29/2013 | US20130220809 Nanopore-facilitated single molecule detection of nucleic acid |
| 08/29/2013 | US20130219998 Rotating system and method for testing engine lubricants |
| 08/29/2013 | US20130219990 Agglomeration and charge loss sensor for measuring particulate matter |
| 08/29/2013 | US20130219988 No sensor and sensor systems |
| 08/29/2013 | US20130219987 Novel Glucose Tolerance Test and Composition for Use |
| 08/29/2013 | DE102012101480A1 Verfahren zur Herstellung oder Fusion von planaren Lipiddoppelschichten Process for the preparation or fusion of planar lipid bilayers |
| 08/29/2013 | DE102012011160B3 Method for determining wear of rubber buffers in vehicle, involves achieving malfunction criterion when current signal patterns deviate from preset value of calibration signal patterns, and outputting malfunction signal |
| 08/29/2013 | DE102012003595A1 Evaluating resistance of organism against oxidative stress by determining antioxidant property of body fluid, involves analyzing antioxidant including ascorbic acid and uric acid and performing point-of-care testing studies in whole blood |
| 08/28/2013 | EP2631657A1 Immunoassay for the detection of the 22kDa C-terminal fragment (CAF) of agrin |
| 08/28/2013 | EP2631656A1 Marker for amyotrophic lateral sclerosis, and use thereof |
| 08/28/2013 | EP2631655A1 Gel particle measurement reagent and measurement method using same |
| 08/28/2013 | EP2631654A1 Neuropeptide release assay for sodium channels |
| 08/28/2013 | EP2631653A1 Identification of modulators of binding properties of antibodies reactive with a member of the insulin receptor family |
| 08/28/2013 | EP2631652A1 Label free biosensor |
| 08/28/2013 | EP2631651A1 Luminogenic and nonluminogenic multiplex assay |
| 08/28/2013 | EP2631650A1 Composition comprising alpha-1,2 fucosyl glycans for treating gastrointestinal disorders |
| 08/28/2013 | EP2631649A1 Method and device for the rapid diagnosis of diseases in faecal samples |
| 08/28/2013 | EP2631648A2 Therapeutic target for periodontal disease. |
| 08/28/2013 | EP2631647A1 Method for measuring calcineurin activity |
| 08/28/2013 | EP2631646A1 Biomarker for alzheimer's disease or mild cognitive impairment |
| 08/28/2013 | EP2631645A1 Blood filtering kit |
| 08/28/2013 | EP2631644A1 Providing a strength related factor of wood material |
| 08/28/2013 | EP2631640A2 Use of eddy currents to analyze polycrystalline diamond |
| 08/28/2013 | EP2631638A2 Use of capacitance to analyze polycrystalline diamond |
| 08/28/2013 | EP2631637A2 Use of capacitance and eddy currents to analyze polycrystalline diamond |
| 08/28/2013 | EP2631247A1 Means and methods of measuring parathyroid hormone in patients suffering from oxidative stress |
| 08/28/2013 | EP2631240A1 Optimized probes and primers and methods of using same for the detection, screening, quantitation, isolation and sequencing of Cytomegalovirus and Epstein-Barr virus |
| 08/28/2013 | EP2631007A1 Device for parallelization and performance increase in microarray-immunoassays with solid, non-porous capture-zone |
| 08/28/2013 | EP2630806A1 Diagnostic system and diagnosing method, housing component of a lubricant container |
| 08/28/2013 | EP2630517A2 Nmr systems and methods for the rapid detection of analytes |
| 08/28/2013 | EP2630502A2 Analyte sensors, methods for preparing and using such sensors, and methods of detecting analyte activity |
| 08/28/2013 | EP2630501A2 Improved identification of pre-diabetes using a combination of mean glucose and 1,5-anhydroglucitol markers |
| 08/28/2013 | EP2630500A1 Methods for selecting competent oocytes and competent embryos with high potential for pregnancy outcome |
| 08/28/2013 | EP2630499A2 Biomarkers for hcv infected patients |
| 08/28/2013 | EP2630498A2 Prognostic biomarkers in patients with ovarian cancer |
| 08/28/2013 | EP2630497A1 Quantitation of urinary tissue factor for the diagnosis and screening of cancer |
| 08/28/2013 | EP2630496A1 Method for diagnosis of aneuploid colorectal tumours |
| 08/28/2013 | EP2630495A1 Methods for determining anti-drug antibody isotypes |
| 08/28/2013 | EP2630494A1 Method for functionalising surfaces for analyte detection |
| 08/28/2013 | EP2630493A2 Antigen-specific, tolerance-inducing microparticles and uses thereof |
| 08/28/2013 | EP2630492A2 Internal focus reference beads for imaging cytometry |
| 08/28/2013 | EP2630491A2 Chemosensory receptor ligand-based therapies |
| 08/28/2013 | EP2630490A1 Body fluid bin1 as a marker of cardiac health |
| 08/28/2013 | EP2630489A2 Methods for selecting medications for treating patients having attention-deficit hyperactivity disorder |
| 08/28/2013 | EP2630488A1 Method and probe for monitoring oxygen status in live mammalian cells |
| 08/28/2013 | EP2630487A1 Method for determining a degree of infection |
| 08/28/2013 | EP2630486A1 Yarn clearer and method for clearing yarn |
| 08/28/2013 | EP2630485A1 Device for analyzing at least one hydrocarbon contained in a drilling fluid and associated method |
| 08/28/2013 | EP2630484A1 Method for evaluating the quantity of methane produced by a dairy ruminant |
| 08/28/2013 | EP2630483A2 Enhanced method for monitoring the deposition of organic materials in a papermaking process |
| 08/28/2013 | EP2630479A2 Apparatus and method for measuring binding kinetics with a resonating sensor |
| 08/28/2013 | EP2630475A1 Diagnostic method and treatment |
| 08/28/2013 | EP2630472A1 Method of identifying a material |
| 08/28/2013 | EP2630468A1 An apparatus and associated methods |
| 08/28/2013 | EP2630262A2 Detection of target nucleic acid sequences using dual-labeled immobilized probes on solid phase |
| 08/28/2013 | EP2630256A1 Use of specific genes for the prognosis of lung cancer and the corresponding prognosis method |
| 08/28/2013 | EP2630252A1 Composition and apparatus for detecting urease in gastric contents |
| 08/28/2013 | EP2630251A1 Method for identifying activation of transferases |
| 08/28/2013 | EP2630250A1 Sensor |
| 08/28/2013 | EP2630242A1 Identification of antibodies specific for lyssaviruses and methods of their use |
| 08/28/2013 | EP2630241A2 Treatment of alpha-l-iduronidase (idua) related diseases by inhibition of natural antisense transcript to idua |
| 08/28/2013 | EP2630196A1 Cyanine dyes and their conjugates |
| 08/28/2013 | EP2630195A1 Novel amine-substituted tricyclic fluorescent dyes |
| 08/28/2013 | EP2630162A2 Polyvalent chimeric ospc vaccinogen and diagnostic antigen |
| 08/28/2013 | EP2630077A2 Chromophoric polymer dots |
| 08/28/2013 | EP2629675A1 Magnetic instrument for the homing of therapeutic cells and the elimination of excess therapeutic cells |
| 08/28/2013 | EP2629663A2 Devices and formulations for detecting, screening and monitoring levels of certain constituents in bodily fluids and method |
| 08/28/2013 | CN203164704U Remote real-time water quality monitoring and control system |
| 08/28/2013 | CN203164698U On-line remote quality control system for water quality monitor |
| 08/28/2013 | CN203164192U Blood type test box |
| 08/28/2013 | CN203164191U Rapid carcino embryonie antigen (CEA) detection kit |
| 08/28/2013 | CN203164190U A kit for confirmation of hepatitis C virus (HCV) antibodies |
| 08/28/2013 | CN203164189U Beta-stimulant rapid test card |
| 08/28/2013 | CN203164188U Rapid detection device for malachite green |
| 08/28/2013 | CN203164187U Gold label detector for colloidal gold |
| 08/28/2013 | CN203164186U Cortisol enzyme-linked immunosorbent assay micro-pore, micro-pore strip and kit |
| 08/28/2013 | CN203164185U Trace magnetic bead separator |
| 08/28/2013 | CN203164184U Test paper insert card |
| 08/28/2013 | CN203164183U Urine test cup |
| 08/28/2013 | CN203164182U Novel urine sample inspection cup |
| 08/28/2013 | CN203164181U Novel human body exhaled alcohol concentration testing device |